Brief: Embecta Q3 Revenue USD 286.1 Million
08/08/2023 11:30
Aug 08 (Reuters) - Embecta Q3 dividend USD 0.15. * Q3 adjusted gross profit USD 189.6 million * Q3 operating income USD 51.3 million * Q3 gross profit USD 189.5 million * Q3 adjusted EBITDA USD 92.2 million * Q3 adjusted operating income USD 79.8 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel